Lodestar Investment Counsel’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | $3M | Sell |
73,047
-935
| -1% | -$38.4K | 0.31% | 65 |
|
|
2019
Q1 | $2.98M | Hold |
73,982
| – | – | 0.32% | 63 |
|
|
2018
Q4 | $3.06M | Buy |
73,982
+516
| +0.7% | +$21.4K | 0.37% | 58 |
|
|
2018
Q3 | $3.07M | Hold |
73,466
| – | – | 0.33% | 58 |
|
|
2018
Q2 | $2.53M | Buy |
73,466
+392
| +0.5% | +$13.5K | 0.29% | 60 |
|
|
2018
Q1 | $2.46M | Sell |
73,074
-7,420
| -9% | -$250K | 0.29% | 61 |
|
|
2017
Q4 | $2.77M | Buy |
80,494
+79
| +0.1% | +$2.72K | 0.32% | 62 |
|
|
2017
Q3 | $2.72M | Buy |
80,415
+2,899
| +4% | +$98.2K | 0.33% | 61 |
|
|
2017
Q2 | $2.47M | Sell |
77,516
-161
| -0.2% | -$5.13K | 0.31% | 60 |
|
|
2017
Q1 | $2.52M | Sell |
77,677
-1,884
| -2% | -$61.1K | 0.33% | 61 |
|
|
2016
Q4 | $2.45M | Sell |
79,561
-316
| -0.4% | -$9.74K | 0.33% | 60 |
|
|
2016
Q3 | $2.57M | Buy |
79,877
+54
| +0.1% | +$1.74K | 0.35% | 59 |
|
|
2016
Q2 | $2.67M | Sell |
79,823
-2,481
| -3% | -$82.9K | 0.38% | 58 |
|
|
2016
Q1 | $2.31M | Buy |
82,304
+24,204
| +42% | +$681K | 0.33% | 62 |
|
|
2015
Q4 | $1.78M | Buy |
58,100
+366
| +0.6% | +$11.2K | 0.28% | 65 |
|
|
2015
Q3 | $1.72M | Buy |
57,734
+3,223
| +6% | +$96.1K | 0.29% | 65 |
|
|
2015
Q2 | $1.73M | Hold |
54,511
| – | – | 0.27% | 69 |
|
|
2015
Q1 | $1.8M | Sell |
54,511
-194
| -0.4% | -$6.4K | 0.28% | 66 |
|
|
2014
Q4 | $1.62M | Sell |
54,705
-975
| -2% | -$28.8K | 0.46% | 44 |
|
|
2014
Q3 | $1.56M | Sell |
55,680
-6,060
| -10% | -$170K | 0.48% | 44 |
|
|
2014
Q2 | $1.74M | Sell |
61,740
-169
| -0.3% | -$4.76K | 0.52% | 43 |
|
|
2014
Q1 | $1.89M | Buy |
61,909
+4,111
| +7% | +$125K | 0.59% | 43 |
|
|
2013
Q4 | $1.68M | Sell |
57,798
-633
| -1% | -$18.4K | 0.55% | 43 |
|
|
2013
Q3 | $1.59M | Buy |
58,431
+527
| +0.9% | +$14.4K | 0.58% | 40 |
|
|
2013
Q2 | $1.54M | Buy |
+57,904
| New | +$1.54M | 0.59% | 41 |
|